Optimer Pharmaceuticals, Inc. (Nasdaq:OPTR) announced 2010 fourth quarter and full year financial results and accomplishments. Optimer reported a net loss for the three months ended December 31, 2010 of $11.9 million, or $0.31 per common share, as compared to a net loss of $9.4 million, or $0.28 per common share, for the same period in 2009. Optimer reported a net loss for the year ended December 31, 2010 of $47.3 million, or $1.25 per common share, as compared to a net loss of $42.1 million, or $1.30 per common share, for 2009.
Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products worldwide.
In Kentucky, Oil and gas are produced from more than 1,500 pools from rocks of Cambrian to Pennsylvanian age. Most oil is produced from Mississippian limestone and sandstone in eastern and western Kentucky or from Ordovician limestone and dolomites in southern Kentucky. Most natural gas is produced from the Devonian black shale in eastern Kentucky.
Kentucky’s existing oil and gas infrastructure is extensive. Finding and production costs are low due to the occurrence of shallow resources. Kentucky is centrally located for access and distribution to northern and eastern industrial markets.
Read more at: http://crwewallstreet.com/?p=16786